dextromethorphan hydrobromide 2 MG/ML / guaifenesin 40 MG/ML Oral Suspension
- RxCUI
- 1542452
- RxNorm name
- dextromethorphan hydrobromide 2 MG/ML / guaifenesin 40 MG/ML Oral Suspension
- Display name
- Dextromethorphan/guaiFENesin (Oral Liquid)
- Full name
- dextromethorphan hydrobromide 2 MG/ML / guaifenesin 40 MG/ML Oral Suspension
- Term type
- SCD
- Status
- Active
- Strength
- 10-200 mg/5ml
- Dose form
- Susp
- Route
- Oral Liquid
- Updated
- 2026-10-03 19:28:17
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 082014
- Active start
- 082014
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| dextromethorphan hydrobromide | 2 MG / 1 ML | dextromethorphan | dextromethorphan hydrobromide |
| guaifenesin | 40 MG / 1 ML | guaifenesin | guaifenesin |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Suspension | 316969 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| dextromethorphan | 3289 |
| guaifenesin | 5032 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | dextromethorphan hydrobromide 2 MG/ML / guaiFENesin 40 MG/ML Oral Suspension | 1 | NAMES |
| RxNorm Name | dextromethorphan hydrobromide 2 MG/ML / guaifenesin 40 MG/ML Oral Suspension | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SCD | 1 | ATTRIBUTES |
| RxCUI | 1542452 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 8bbc395c-8a56-4fca-8e5a-974903c3c266 | Better Living Brands LLC Tussin Drug Facts | Safeway | 20211115 |
| f58327d9-3e0a-40e7-b8d5-0fbf31950dab | Target Corporation Cough + Chest Congestion Drug Facts | Target Corporation | 20191213 |
| d3ef0a66-fe69-4f57-89ed-9ac24fbdf8b5 | Kmart Corporation Cough & Chest Congestion Drug Facts | Kmart Corporation | 20191210 |
| a2c9bc04-587a-457b-9c28-b79b8fed786e | American Sales Company Tussin DM Drug Facts | American Sales Company | 20191209 |
| ca8ba04b-3d67-4d82-b1a5-683ee1e04fdb | Meijer Distribution, Inc. Cough + Chest Congestion Adult DM Max Drug Facts | Meijer Distribution Inc | 20191205 |
| 981c7791-8c74-4f8b-80d9-0dc487838203 | HEB Tussin Cough & Chest Congestion DM Drug Facts | H E B | 20191205 |
| 6de75dcf-30c1-4acc-a722-967c91676e4f | Walgreen Co. Wal-Tussin ® DM Max Drug Facts | Walgreen Company | 20191204 |
| 95ab0fa0-9c3c-48bd-a9bd-cb41798d1c1f | Walgreen Co. Wal-Tussin ® DM Max Nighttime Wal-Tussin ® DM Max Drug Facts | Walgreen Company | 20191204 |
| 7f8d7317-be89-4f43-b07e-29914d57d90e | Topco Associates LLC. Tussin DM Max Drug Facts | Topco Associates LLC | 20191203 |
| 0469a578-9569-485c-aa54-a491fa8f6858 | Drug Facts | Aurohealth LLC | 20191128 |
| 53a66dc7-2448-4796-bd66-fbfc1e9d693f | Drug Facts | Aurohealth LLC | 20191128 |
| 72441651-9754-4815-85dd-c8759b56b846 | Dolgencorp, LLC DM Cough & Congestion Relief Drug Facts | Dolgencorp Inc | 20191122 |
| 581ab73d-06a8-4210-8a40-5cc526f7902d | Drug Facts | Marc Glassman, Inc. | Aurohealth LLC | 20191101 |
| 44491651-8344-4146-b7f2-02e10bd25e7e | McKesson Adult Tussin DM Drug Facts | Strategic Sourcing Services LLC | 20191016 |
| 0dc2c158-4992-45cc-838b-f485e5f30f3e | McKesson Adult Tussin DM Drug Facts | Strategic Sourcing Services LLC | 20190827 |
| 019d6575-f17d-468c-ae92-d5183c4cbea8 | Hy-Vee, Inc. Tussin DM Max Drug Facts | HyVee Inc | 20190719 |
| ce928513-1816-406b-8575-81da24afd696 | Perrigo Tussin DM Max Drug Facts | L. Perrigo Company | 20181223 |
| a2ac34ab-ea92-4a1a-ba96-8969b34913d1 | Kroger Co. Tussin DM Max Drug Facts | Kroger Company | 20151019 |
| a2e3be23-0bbf-4f34-81d1-65f48d0bd7f6 | Harris Teeter, LLC Tussin Drug Facts | Harris Teeter, LLC | 20150928 |
| 132e9e0b-7d6f-4c9d-9076-e9879a5afa47 | CVS Pharmacy, Inc. Tussin DM Drug Facts | CVS Pharmacy | 20150714 |
| 3c623a3b-eb5e-4515-989b-c3fd3d5f0dab | Walgreen Co. Wal-Tussin® DM Max Drug Facts | Walgreen Company | 20130608 |
| c87f230e-e2d0-4acd-a3d7-e3bd70e58601 | National Council for Prescription Drug Programs | 20130502 | |
| b4e236ce-b517-4ea9-b37c-9405e1e8ae66 | National Council for Prescription Drug Programs | 20130213 | |
| 79b47d08-276e-482d-bc9b-8cb46ceafdf2 | National Council for Prescription Drug Programs | 20130213 | |
| 3c5f921d-beda-4118-8afe-bf5b80b9afa3 | National Council for Prescription Drug Programs | 20120724 | |
| 1438efd5-e381-457f-ac07-4942900547a2 | National Council for Prescription Drug Programs | 20120724 | |
| b47d065d-26b6-47bd-93a2-f21640a76fbd | National Council for Prescription Drug Programs | 20120724 | |
| 5ad81d52-9579-40f9-b4a8-bf877bf96490 | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | R05CA | Expectorants | ATC1-4 | guaifenesin | |
| ATC | R05DA | Opium alkaloids and derivatives | ATC1-4 | dextromethorphan | |
| FDASPL | N0000193956 | Expectorant | EPC | has_epc | guaifenesin |
| FDASPL | N0000182149 | Sigma-1 Agonist | EPC | has_epc | dextromethorphan |
| FDASPL | N0000181821 | Uncompetitive N-methyl-D-aspartate Receptor Antagonist | EPC | has_epc | dextromethorphan |
| FDASPL | N0000182147 | Sigma-1 Receptor Agonists | MOA | has_moa | dextromethorphan |
| FDASPL | N0000181819 | Uncompetitive NMDA Receptor Antagonists | MOA | has_moa | dextromethorphan |
| MEDRT | D003915 | Dextromethorphan | CHEM | has_ingredient | dextromethorphan hydrobromide |
| MEDRT | D003915 | Dextromethorphan | CHEM | has_ingredient | dextromethorphan |
| MEDRT | D006140 | Guaifenesin | CHEM | has_ingredient | guaifenesin |
| MEDRT | D001991 | Bronchitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | guaifenesin |
| MEDRT | D003371 | Cough | DISEASE | may_prevent | dextromethorphan |
| MEDRT | D003371 | Cough | DISEASE | may_treat | guaifenesin |
| MEDRT | D003371 | Cough | DISEASE | may_treat | dextromethorphan hydrobromide |
| MEDRT | D003371 | Cough | DISEASE | may_prevent | dextromethorphan hydrobromide |
| MEDRT | D003371 | Cough | DISEASE | may_treat | dextromethorphan |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | dextromethorphan hydrobromide |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | dextromethorphan |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | guaifenesin |
| MEDRT | D007827 | Laryngitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D010612 | Pharyngitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | guaifenesin |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D014917 | Whooping Cough | DISEASE | may_treat | guaifenesin |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | dextromethorphan |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | dextromethorphan hydrobromide |
| MEDRT | N0000000109 | Serotonin Uptake Inhibitors | MOA | has_moa | dextromethorphan hydrobromide |
| MEDRT | N0000000109 | Serotonin Uptake Inhibitors | MOA | has_moa | dextromethorphan |
| MEDRT | N0000182147 | Sigma-1 Receptor Agonists | MOA | has_moa | dextromethorphan |
| MEDRT | N0000182147 | Sigma-1 Receptor Agonists | MOA | has_moa | dextromethorphan hydrobromide |
| MEDRT | N0000181819 | Uncompetitive NMDA Receptor Antagonists | MOA | has_moa | dextromethorphan |
| MEDRT | N0000181819 | Uncompetitive NMDA Receptor Antagonists | MOA | has_moa | dextromethorphan hydrobromide |
| MEDRT | N0000008701 | Decreased Medullary Respiratory Drive | PE | has_pe | dextromethorphan |
| MEDRT | N0000008701 | Decreased Medullary Respiratory Drive | PE | has_pe | dextromethorphan hydrobromide |
| MEDRT | N0000008867 | Decreased Respiratory Secretion Viscosity | PE | has_pe | guaifenesin |
| MEDRT | N0000009560 | Increased Respiratory Secretions | PE | has_pe | guaifenesin |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 2 MG/ML / 40 MG/ML |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | VUID | 4033186 |
| NAMES | Prescribable Synonym | dextromethorphan HBr 20 MG / guaiFENesin 400 MG in 10 mL Oral Suspension |
| NAMES | Tallman Synonym | dextromethorphan HBr 10 MG / guaiFENesin 200 MG per 5 ML Oral Suspension |
| NAMES | Tallman Synonym | dextromethorphan HBr 20 MG / guaiFENesin 400 MG per 10 ML Oral Suspension |
| NAMES | Tallman Synonym | dextromethorphan hydrobromide 2 MG/ML / guaiFENesin 40 MG/ML Oral Suspension |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |